{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T16:39:10Z","timestamp":1782232750024,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"17","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2004,9,1]]},"DOI":"10.1038\/sj.gt.3302303","type":"journal-article","created":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T09:33:55Z","timestamp":1088674435000},"page":"1331-1341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Inhibition of papilloma progression by antisense oligonucleotides targeted to HPV11 E6\/E7 RNA"],"prefix":"10.1038","volume":"11","author":[{"given":"G A","family":"Clawson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Q","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sivarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Thiboutot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N D","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,7,1]]},"reference":[{"key":"BF3302303_CR1","first-page":"131","volume":"186","author":"H zur Hausen","year":"1994","unstructured":"zur Hausen H . Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994; 186: 131\u2013156.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BF3302303_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"J Walboomers","year":"1999","unstructured":"Walboomers J et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12\u201319.","journal-title":"J Pathol"},{"key":"BF3302303_CR3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0046-8177(92)90232-R","volume":"23","author":"MEA Stoler","year":"1992","unstructured":"Stoler MEA . Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum Pathol 1992; 23: 117\u2013128.","journal-title":"Hum Pathol"},{"key":"BF3302303_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0002-9378(86)90405-9","volume":"154","author":"WEA Lancaster","year":"1986","unstructured":"Lancaster WEA . Human papillomavirus deoxyribonucleic acid in cervical carcinoma from primary and metastatic sites. Am J Obstet Gynecol 1986; 154: 115\u2013119.","journal-title":"Am J Obstet Gynecol"},{"key":"BF3302303_CR5","first-page":"5019s","volume":"51","author":"P Howley","year":"1991","unstructured":"Howley P . Role of the human papillomaviruses in human cancer. Cancer Res 1991; 51: 5019s\u20135022s.","journal-title":"Cancer Res"},{"key":"BF3302303_CR6","first-page":"2055","volume-title":"Virology","author":"P Howley","year":"1996","unstructured":"Howley P . Papillomavirinea: the viruses and their replication. In: Fields BDK, Howley P (eds). Virology. Lippencott-Raven: Philadelphia, 1996, p 2055."},{"key":"BF3302303_CR7","first-page":"197","volume":"12","author":"K Munger","year":"1992","unstructured":"Munger K, Scheffner M, Huibregtse J, Howley P . Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. Cancer Surv 1992; 12: 197\u2013217.","journal-title":"Cancer Surv"},{"key":"BF3302303_CR8","doi-asserted-by":"publisher","first-page":"5320","DOI":"10.1073\/pnas.91.12.5320","volume":"91","author":"R Slebos","year":"1994","unstructured":"Slebos R et al. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci (USA) 1994; 91: 5320\u20135324.","journal-title":"Proc Natl Acad Sci (USA)"},{"key":"BF3302303_CR9","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1128\/jvi.71.4.2905-2912.1997","volume":"71","author":"D Jones","year":"1997","unstructured":"Jones D, Munger K . Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J Virol 1997; 71: 2905\u20132912.","journal-title":"J Virol"},{"key":"BF3302303_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"N Munoz","year":"2003","unstructured":"Munoz N et al. Epidemiological classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518\u2013527.","journal-title":"N Engl J Med"},{"key":"BF3302303_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/(SICI)1096-9896(199703)181:3<253::AID-PATH755>3.0.CO;2-0","volume":"181","author":"J Walboomers","year":"1997","unstructured":"Walboomers J, Meijer C . Do HPV-negative cervical carcinomas exist? (Editorial). J Pathol 1997; 181: 253\u2013254.","journal-title":"J Pathol"},{"key":"BF3302303_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<1::AID-PATH432>3.0.CO;2-P","volume":"189","author":"C Herrington","year":"1999","unstructured":"Herrington C . Do HPV-negative cervical carcinomas exist? \u2013 revisited (Editorial; Comment). J Pathol 1999; 189: 1\u20133.","journal-title":"J Pathol"},{"key":"BF3302303_CR13","first-page":"251","volume":"1","author":"M Durst","year":"1987","unstructured":"Durst M et al. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus (HPV) type 16 DNA. Oncogene 1987; 1: 251\u2013256.","journal-title":"Oncogene"},{"key":"BF3302303_CR14","first-page":"1529","volume":"4","author":"M Barbosa","year":"1989","unstructured":"Barbosa M, Schlegel R . The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 1989; 4: 1529\u20131532.","journal-title":"Oncogene"},{"key":"BF3302303_CR15","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1128\/jvi.66.3.1655-1664.1992","volume":"66","author":"C Meyers","year":"1992","unstructured":"Meyers C, Harry J, Lin Y, Wettstein F . Identification of three transforming proteins encoded by cottontail rabbit papillomavirus. J Virol 1992; 66: 1655\u20131664.","journal-title":"J Virol"},{"key":"BF3302303_CR16","doi-asserted-by":"publisher","first-page":"4816","DOI":"10.1073\/pnas.88.11.4816","volume":"88","author":"J Brandsma","year":"1991","unstructured":"Brandsma J, Yang Z, Barthold S, Johnson E . Use of a rapid, efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus DNA. Proc Natl Acad Sci USA 1991; 88: 4816\u20134820.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302303_CR17","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/jvi.63.3.1441-1447.1989","volume":"63","author":"D Smotkin","year":"1989","unstructured":"Smotkin D, Prokoph H, Wettstein F . Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J Virol 1989; 63: 1441\u20131447.","journal-title":"J Virol"},{"key":"BF3302303_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/ijc.2910510527","volume":"51","author":"M Von Knebel Doeberitz","year":"1992","unstructured":"Von Knebel Doeberitz M, Rittmuller C, zur Hausen H, Durst M . Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA. Int J Cancer 1992; 51: 831\u2013834.","journal-title":"Int J Cancer"},{"key":"BF3302303_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1089\/oli.1.1999.9.441","volume":"9","author":"L Alvarez-Salas","year":"1999","unstructured":"Alvarez-Salas L, Arpawong T, DiPaolo J . Growth inhibition of cervical tumor cells by antisense oligodeoxynucleotides directed to the human papillomavirus type 16 E6 gene. Antisense Nucleic Acid Drug Dev 1999; 9: 441\u2013450.","journal-title":"Antisense Nucleic Acid Drug Dev"},{"key":"BF3302303_CR20","first-page":"263","volume":"2","author":"Z Chen","year":"1995","unstructured":"Chen Z et al. Effectiveness of three ribozymes for cleavage of an RNA transcript from human papillomavirus type 18. Cancer Gene Ther 1995; 2: 263\u2013271.","journal-title":"Cancer Gene Ther"},{"key":"BF3302303_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1006\/gyno.2000.5916","volume":"78","author":"C Choo","year":"2000","unstructured":"Choo C et al. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells. Gynecol Oncol 2000; 78: 293\u2013301.","journal-title":"Gynecol Oncol"},{"key":"BF3302303_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1006\/gyno.1996.0310","volume":"63","author":"K Hamada","year":"1996","unstructured":"Hamada K et al. Adenovirus-mediated transfer of HPV 16 E6\/E7 antisense RNA to human cervical cancer cells. Gynecol Oncol 1996; 63: 219\u2013227.","journal-title":"Gynecol Oncol"},{"key":"BF3302303_CR23","first-page":"19","volume":"2","author":"G Hu","year":"1995","unstructured":"Hu G et al. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papillomavirus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Cancer Gene Ther 1995; 2: 19\u201332.","journal-title":"Cancer Gene Ther"},{"key":"BF3302303_CR24","first-page":"215","volume":"12","author":"Y Huang","year":"1996","unstructured":"Huang Y et al. Stable expression of anti-HPV 16 E7-ribozyme in CV-1 cell lines. Chin J Biotechnol 1996; 12: 215\u2013220.","journal-title":"Chin J Biotechnol"},{"key":"BF3302303_CR25","first-page":"2485","volume":"16","author":"K Lappalainen","year":"1996","unstructured":"Lappalainen K et al. Effects of liposomal antisense oligonucleotides on mRNA and protein levels of the HPVE7 oncogene. Anticancer Res 1996; 16: 2485\u20132492.","journal-title":"Anticancer Res"},{"key":"BF3302303_CR26","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0166-3542(00)00129-7","volume":"48","author":"E Lewis","year":"2000","unstructured":"Lewis E et al. Non-specific antiviral activity of antisense molecules targeted to the E1 region of human papillomavirus. Antiviral Res 2000; 48: 187\u2013196.","journal-title":"Antiviral Res"},{"key":"BF3302303_CR27","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1093\/nar\/27.7.1585","volume":"27","author":"F Venturini","year":"1999","unstructured":"Venturini F et al. Kinetic selection of HPV 16 E6\/E7-directed antisense nucleic acids: antiproliferative effects on HPV 16-transformed cells. Nucleic Acids Res 1999; 27: 1585\u20131592.","journal-title":"Nucleic Acids Res"},{"key":"BF3302303_CR28","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1017\/S1355838201001595","volume":"7","author":"W-H Pan","year":"2001","unstructured":"Pan W-H et al. A selection system for identifying accessible sites in target RNAs. RNA 2001; 7: 610\u2013621.","journal-title":"RNA"},{"key":"BF3302303_CR29","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/S0000-000X(00)00000-0","volume":"7","author":"WH Pan","year":"2003","unstructured":"Pan WH, Xin P, Bui V, Clawson G . Rapid Identification of efficient target cleavage sites using a hammerhead ribozyme library in an iterative manner. Mol Ther 2003; 7: 128\u2013138.","journal-title":"Mol Ther"},{"key":"BF3302303_CR30","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ymthe.2003.12.013","volume":"9","author":"W Pan","year":"2004","unstructured":"Pan W, Xin P, Morrey J, Clawson G . A self-processing ribozyme cassette: utility against human papillomavirus 11 E6\/E7 mRNA and hepatitis B virus. Mol Ther 2004; 9: 596\u2013606.","journal-title":"Mol Ther"},{"key":"BF3302303_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nbt0797-647","volume":"15","author":"N Templeton","year":"1997","unstructured":"Templeton N et al. Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotech 1997; 15: 647\u2013652.","journal-title":"Nat Biotech"},{"key":"BF3302303_CR32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/jvi.61.2.590-593.1987","volume":"61","author":"J Kreider","year":"1987","unstructured":"Kreider J et al. Laboratory production in vivo of infectious human papillomavirus type 11. J Virol 1987; 61: 590\u2013593.","journal-title":"J Virol"},{"key":"BF3302303_CR33","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1099\/0022-1317-73-5-1261","volume":"73","author":"N Christensen","year":"1992","unstructured":"Christensen N, Kreider J, Shah K, Rando R . Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions. J Gen Virol 1992; 73: 1261\u20131267.","journal-title":"J Gen Virol"},{"key":"BF3302303_CR34","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1128\/jvi.64.11.5678-5681.1990","volume":"64","author":"N Christensen","year":"1990","unstructured":"Christensen N et al. Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. J Virol 1990; 64: 5678\u20135681.","journal-title":"J Virol"},{"key":"BF3302303_CR35","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1099\/0022-1317-75-9-2271","volume":"75","author":"N Christensen","year":"1994","unstructured":"Christensen N et al. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. J Gen Virol 1994; 75: 2271\u20132276.","journal-title":"J Gen Virol"},{"key":"BF3302303_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1006\/viro.1994.1649","volume":"205","author":"N Christensen","year":"1994","unstructured":"Christensen N et al. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology 1994; 205: 329\u2013335.","journal-title":"Virology"},{"key":"BF3302303_CR37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0190-9622(98)70243-9","volume":"38","author":"K Beutner","year":"1998","unstructured":"Beutner K et al. Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 1998; 38: 230\u2013239.","journal-title":"J Am Acad Dermatol"},{"key":"BF3302303_CR38","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1038\/71020","volume":"5","author":"FS Santiago","year":"1999","unstructured":"Santiago FS et al. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med 1999; 5: 1438\u20131441.","journal-title":"Nat Med"},{"key":"BF3302303_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1385\/1-59259-746-7:125","volume-title":"Methods in Molecular Biology, Vol. 252: Ribozymes and siRNA Protocols, 2nd edn, Chapter 9","author":"W Pan","year":"2004","unstructured":"Pan W, Clawson G . Identification of efficient cleavage sites in long target RNAs. In: Sioud M (ed). Methods in Molecular Biology, Vol. 252: Ribozymes and siRNA Protocols, 2nd edn, Chapter 9, Humana Press: Totowa, NJ, 2004, pp 125\u2013144."},{"key":"BF3302303_CR40","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1128\/MCB.19.6.4047","volume":"19","author":"M Herasse","year":"1999","unstructured":"Herasse M et al. Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events. Mol Cell Biol 1999; 19: 4047\u20134055.","journal-title":"Mol Cell Biol"},{"key":"BF3302303_CR41","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","volume":"30","author":"M Pfaffl","year":"2002","unstructured":"Pfaffl M, Horgan G, Dempfle L . Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002; 30: e36.","journal-title":"Nucleic Acids Res"},{"key":"BF3302303_CR42","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1021\/js9700053","volume":"86","author":"L Lieb","year":"1997","unstructured":"Lieb L et al. Description of the intrafollicular delivery of large molecular weight molecules to follicles of human scalp skin in vitro. J Pharm Sci 1997; 86: 1022\u20131029.","journal-title":"J Pharm Sci"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302303.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302303","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302303.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:36:41Z","timestamp":1648615001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,1]]},"references-count":42,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2004,9,1]]}},"alternative-id":["BF3302303"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302303","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,1]]},"assertion":[{"value":"2 October 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}